Steamboat Capital Partners’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.48M Sell
108,366
-1,371
-1% -$93.5K 1.81% 20
2026
Q1
$7.09M Sell
109,737
-34,503
-24% -$2.43M 1.76% 27
2025
Q4
$9.71M Buy
144,240
+1,663
+1% +$112K 2.66% 13
2025
Q3
$10.5M Sell
142,577
-28,923
-17% -$1.92M 2.72% 12
2025
Q2
$8.92M Buy
171,500
+21,500
+14% +$1.22M 2.54% 15
2025
Q1
$9.57M Sell
150,000
-99,751
-40% -$5.79M 2.89% 14
2024
Q4
$11.9M Buy
249,751
+75,890
+44% +$3.89M 3.69% 8
2024
Q3
$9.95M Sell
173,861
-3,694
-2% -$212K 3.14% 12
2024
Q2
$9.3M Buy
177,555
+5,606
+3% +$246K 3.41% 10
2024
Q1
$6.99M Buy
171,949
+2,865
+2% +$107K 2.41% 17
2023
Q4
$6.25M Sell
169,084
-27,814
-14% -$1.05M 2.35% 20
2023
Q3
$7.52M Buy
196,898
+3,653
+2% +$150K 2.79% 16
2023
Q2
$6.97M Sell
193,245
-6,755
-3% -$230K 2.4% 18
2023
Q1
$7.64M Buy
+200,000
New +$9.38M 2.53% 18

Other funds holding HALO

Steamboat Capital Partners's HALO Position: Q2 2026 in Review

Steamboat Capital Partners reduced its Halozyme (HALO) stake by 1.2% in Q2 2026, selling an estimated $93.5K and leaving 108,366 shares worth $8.48M. The position accounts for 1.81% of the portfolio, ranked #20.

Steamboat Capital Partners first reported a position in HALO in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.9M in Q4 2024. 672 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Steamboat Capital Partners held 108,366 shares of Halozyme worth $8.48M as of Q2 2026.
  • Steamboat Capital Partners sold 1,371 Halozyme shares in Q2 2026, an estimated $93.5K.
  • Halozyme made up 1.81% of Steamboat Capital Partners's portfolio in Q2 2026, its #20 holding.
  • Steamboat Capital Partners first reported a position in Halozyme in Q1 2023 and has held it in 14 quarters since.
  • Steamboat Capital Partners's Halozyme position peaked at $11.9M in Q4 2024.
  • 672 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Steamboat Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.